FACTORS ASSOCIATED WITH PRESCRIBING OF TERIFLUNOMIDE AND DIMETHYL FUMARATE VERSUS FINGOLIMOD IN MULTIPLE SCLEROSIS

被引：0
|
作者：
Earla, J. r [1 ]
Hutton, G. J. [2 ]
Aparasu, R. R. [3 ]
机构：
[1] Univ Houston, Coll Pharm, Fords, NJ USA
[2] Baylor Coll Med, McNair Campus, Houston, TX 77030 USA
[3] Univ Houston, Coll Pharm, Houston, TX 77030 USA
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
HSD13
引用
收藏
页码：S482 / S482
页数：1
相关论文
共 50 条
  • [1] Comparison of fingolimod, dimethyl fumarate and teriflunomide for multiple sclerosis
    Kalincik, Tomas
    Havrdova, Eva Kubala
    Horakova, Dana
    Izquierdo, Guillermo
    Prat, Alexandre
    Girard, Marc
    Duquette, Pierre
    Grammond, Pierre
    Onofrj, Marco
    Lugaresi, Alessandra
    Ozakbas, Serkan
    Kappos, Ludwig
    Kuhle, Jens
    Terzi, Murat
    Lechner-Scott, Jeannette
    Boz, Cavit
    Grand'Maison, Francois
    Prevost, Julie
    Sola, Patrizia
    Ferraro, Diana
    Granella, Franco
    Trojano, Maria
    Bergamaschi, Roberto
    Pucci, Eugenio
    Turkoglu, Recai
    McCombe, Pamela A.
    Van Pesch, Vincent
    Van Wijmeersch, Bart
    Solaro, Claudio
    Ramo-Tello, Cristina
    Slee, Mark
    Alroughani, Raed
    Yamout, Bassem
    Shaygannejad, Vahid
    Spitaleri, Daniele
    Luis Sanchez-Menoyo, Jose
    Ampapa, Radek
    Hodgkinson, Suzanne
    Karabudak, Rana
    Butler, Ernest
    Vucic, Steve
    Jokubaitis, Vilija
    Spelman, Tim
    Butzkueven, Helmut
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2019, 90 (04): : 458 - 468
  • [2] Natalizumab versus fingolimod and dimethyl fumarate in multiple sclerosis treatment
    Vollmer, Brandi L.
    Nair, Kavita V.
    Sillau, Stefan
    Corboy, John R.
    Vollmer, Timothy
    Alvarez, Enrique
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2019, 6 (02): : 252 - 262
  • [3] Comparison of fingolimod, dimethyl fumarate and teriflunomide for multiple sclerosis (vol 90, pg 458, 2019)
    Kalincik, T.
    Havrdova, Kubala E.
    Horakova, D.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2019, 90 (07): : E5 - E5
  • [4] Rituximab versus natalizumab, fingolimod, and dimethyl fumarate in multiple sclerosis treatment
    Vollmer, Brandi L.
    Nair, Kavita
    Sillau, Stefan
    Corboy, John R.
    Vollmer, Timothy
    Alvarez, Enrique
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2020, 7 (09): : 1466 - 1476
  • [5] COST EFFECTIVENESS ANALYSIS OF DIMETHYL FUMARATE VERSUS TERIFLUNOMIDE FOR THE TREATMENT OF MULTIPLE SCLEROSIS
    Ruiz, L.
    Machado, L.
    Toro-Diaz, H.
    Cele, C.
    Hernandez, L.
    Harrington, A.
    VALUE IN HEALTH, 2017, 20 (09) : A724 - A724
  • [6] COST-UTILITY ANALYSIS OF DIMETHYL FUMARATE VERSUS FINGOLIMOD AND TERIFLUNOMIDE IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS IN COLOMBIA
    Ordonez, J.
    Serafini, P.
    Machado, M.
    VALUE IN HEALTH, 2016, 19 (07) : A434 - A434
  • [7] FACTORS ASSOCIATED WITH PRESCRIBING OF ORAL FINGOLIMOD IN MULTIPLE SCLEROSIS
    Earla, J. R.
    Hutton, G. J.
    Thornton, J. D.
    Chen, H.
    Johnson, M. L.
    Aparasu, R.
    VALUE IN HEALTH, 2020, 23 : S272 - S272
  • [8] DIMETHYL FUMARATE VERSUS FINGOLIMOD AND TERIFLUNOMIDE FOR THE TREATMENT OF RELAPSING-REMITTING MULTIPLE SCLEROSIS IN COLOMBIA: A COST-UTILITY ANALYSIS
    Ordonez, J. E.
    VALUE IN HEALTH, 2017, 20 (05) : A194 - A194
  • [9] Effectiveness of fingolimod, dimethyl fumarate and teriflunomide in relapsing-remitting multiple sclerosis: a comparative longitudinal study
    Kalincik, T.
    Spelman, T.
    Jokubaitis, V.
    Horakova, D.
    Havrdova, E.
    Izquierdo, G.
    Prat, A.
    Girard, M.
    Duquette, P.
    Lugaresi, A.
    Grammond, P.
    Alroughani, R.
    Lechner-Scott, J.
    Prevost, J.
    Terzi, M.
    Grand'Maison, F.
    Boz, C.
    Trojano, M.
    Van Wijmeersch, B.
    Pucci, E.
    Granella, F.
    Turkoglu, R.
    Sola, P.
    Ferraro, D.
    McCombe, P.
    Solaro, C.
    Van Pesch, V.
    Ozakbas, S.
    Slee, M.
    Spitaleri, D.
    Sanchez-Menoyo, J. L.
    Ampapa, R.
    Hodgkinson, S.
    Karabudak, R.
    Vucic, S.
    Butzkueven, H.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 325 - 327
  • [10] Comparative effectiveness of teriflunomide vs dimethyl fumarate in multiple sclerosis
    Laplaud, David-Axel
    Casey, Romain
    Barbin, Laetitia
    Debouverie, Marc
    De Seze, Jerome
    Brassat, David
    Wiertlewski, Sandrine
    Brochet, Bruno
    Pelletier, Jean
    Vermersch, Patrick
    Edan, Gilles
    Lebrun-Frenay, Christine
    Clavelou, Pierre
    Thouvenot, Eric
    Camdessanche, Jean-Philippe
    Tourbah, Ayman
    Stankoff, Bruno
    Al Khedr, Abdullatif
    Cabre, Philippe
    Lubetzki, Catherine
    Papeix, Caroline
    Berger, Eric
    Heinzlef, Olivier
    Debroucker, Thomas
    Moreau, Thibault
    Gout, Olivier
    Bourre, Bertrand
    Wahab, Abir
    Labauge, Pierre
    Magy, Laurent
    Defer, Gilles
    Guennoc, Anne-Marie
    Maubeuge, Nicolas
    Labeyrie, Celine
    Patry, Ivania
    Nifle, Chantal
    Casez, Olivier
    Michel, Laure
    Rollot, Fabien
    Leray, Emmanuelle
    Vukusic, Sandra
    Foucher, Yohann
    Fontaine, B.
    Marignier, R.
    Durand-Dubief, F.
    Mathey, G.
    Le Page, E.
    Peaureaux-Averseng, D.
    Ouallet, J. C.
    Ruet, A.
    NEUROLOGY, 2019, 93 (07) : E635 - E646
12345